Nahas Sergio Carlos, Nahas Caio Sergio Rizkallah, Silva Filho Edesio Vieira da, Levi Jose Eduardo, Atui Fabio Cesar, Marques Carlos Frederico Sparapan
Surgical Division of Gastroenterology, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Sao Paulo Med J. 2007 Sep 6;125(5):292-4. doi: 10.1590/s1516-31802007000500009.
Highly active antiretroviral therapy (HAART) has turned human immunodeficiency virus (HIV) infection into a chronic condition, and this has led to increased incidence of anal dysplasia among HIV-positive patients. Routine anal evaluation including the anal canal and perianal area is recommended for this population, especially for patients infected by oncogenic human papillomavirus (HPV) types.
A 54-year-old homosexual HIV-positive man presented with a six-year history of recurrent perianal and anal warts. He had previously undergone incomplete surgical excision and fulguration in another institution on two occasions. He had been using HAART over the past two years. He presented some condylomatous spreading lesions occupying part of the anal canal and the perianal skin, and also a well-demarcated slightly painful perianal plaque of dimensions 1.0 x 1.0 cm. Both anal canal Pap smears and biopsies guided by high-resolution anoscopy revealed high-grade squamous intraepithelial lesion. Biopsies of the border of the perianal plaque also revealed high-grade squamous intraepithelial lesion. HPV DNA testing of the anus detected the presence of HPV-16 type. The patient underwent local full-thickness excision of the lesion. Histological analysis on the excised tissue revealed high-grade squamous intraepithelial lesion with one focus of microinvasive squamous cell cancer measuring 1 mm. No lymph vessel or perineural invasion was detected. The patient showed pathological evidence of recurrent anal and perianal high-grade squamous intraepithelial lesions at the sixth-month follow-up and required further ablation of those lesions. However no invasive squamous cell carcinoma recurrence has been detected so far.
高效抗逆转录病毒疗法(HAART)已将人类免疫缺陷病毒(HIV)感染转变为一种慢性疾病,这导致HIV阳性患者中肛门发育异常的发病率增加。建议对该人群进行包括肛管和肛周区域在内的常规肛门评估,特别是对于感染致癌性人乳头瘤病毒(HPV)类型的患者。
一名54岁的同性恋HIV阳性男性,有六年复发性肛周和肛门疣病史。他此前曾在另一家机构接受过两次不完全手术切除和电灼治疗。在过去两年中他一直在使用HAART。他出现了一些占据部分肛管和肛周皮肤的湿疣样扩散性病变,以及一个边界清晰、稍有疼痛、大小为1.0×1.0厘米的肛周斑块。肛管巴氏涂片检查以及在高分辨率肛门镜引导下进行的活检均显示为高级别鳞状上皮内病变。肛周斑块边缘的活检也显示为高级别鳞状上皮内病变。肛门HPV DNA检测发现存在HPV-16型。患者接受了病变的局部全层切除。对切除组织的组织学分析显示为高级别鳞状上皮内病变,有一个微浸润性鳞状细胞癌灶,大小为1毫米。未检测到淋巴管或神经周围侵犯。在六个月的随访中,患者显示出肛门和肛周高级别鳞状上皮内病变复发的病理证据,需要对这些病变进行进一步消融。然而,迄今为止尚未检测到浸润性鳞状细胞癌复发。